{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:22:27Z","timestamp":1776921747095,"version":"3.51.2"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"vor","delay-in-days":3455,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA114340"],"award-info":[{"award-number":["CA114340"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F31-DA021005-01"],"award-info":[{"award-number":["F31-DA021005-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KO2 DA 015349"],"award-info":[{"award-number":["KO2 DA 015349"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 DA 011806"],"award-info":[{"award-number":["P50 DA 011806"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 DA 022935"],"award-info":[{"award-number":["RO1 DA 022935"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 DA 12104"],"award-info":[{"award-number":["RO1 DA 12104"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.2353\/ajpath.2010.090621","type":"journal-article","created":{"date-parts":[[2010,7,8]],"date-time":"2010-07-08T23:05:40Z","timestamp":1278630340000},"page":"984-997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Morphine Suppresses Tumor Angiogenesis through a HIF-1\u03b1\/p38MAPK Pathway"],"prefix":"10.1016","volume":"177","author":[{"given":"Lisa","family":"Koodie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundaram","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabita","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2010.090621_bib1","first-page":"1","article-title":"Oral morphine for cancer pain","volume":"3","author":"Wiffen","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.2353\/ajpath.2010.090621_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1526-4637.2001.002001015.x","article-title":"Functional interactions between tumor and peripheral nerve in a model of cancer pain in the mouse","volume":"2","author":"Cain","year":"2001","journal-title":"Pain Med"},{"key":"10.2353\/ajpath.2010.090621_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/1049909106292170","article-title":"Parenteral morphine prescribing patterns among inpatients with pain from advanced cancer: a prospective survey of intravenous and subcutaneous use","volume":"23","author":"Walsh","year":"2006","journal-title":"Am J Hosp Palliat Care Med"},{"key":"10.2353\/ajpath.2010.090621_bib4","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-2125.1979.tb01047.x","article-title":"Serum morphine concentration after oral administration of diamorphine hydrochloride and morphine sulphate","volume":"8","author":"Aherne","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.2353\/ajpath.2010.090621_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0304-3959(94)00148-8","article-title":"Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients","volume":"61","author":"Tiseo","year":"1995","journal-title":"Pain"},{"key":"10.2353\/ajpath.2010.090621_bib6","first-page":"1846","article-title":"G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation","volume":"63","author":"Tegeder","year":"2003","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.090621_bib7","first-page":"4491","article-title":"Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth","volume":"62","author":"Gupta","year":"2002","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.090621_bib8","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0092-8674(00)81810-3","article-title":"Blood vessel formation: what is its molecular basis?","volume":"87","author":"Folkman","year":"1996","journal-title":"Cell"},{"key":"10.2353\/ajpath.2010.090621_bib9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocrine Rev"},{"key":"10.2353\/ajpath.2010.090621_bib10","first-page":"4221","article-title":"Vascular endothelial growth factor and vascular targeting of solid tumors","volume":"21","author":"Brekken","year":"2002","journal-title":"Anticancer Res"},{"key":"10.2353\/ajpath.2010.090621_bib11","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1006\/jmcc.2001.1480","article-title":"Morphine sulfate inhibits hypoxia-induced vascular endothelial growth factor expression in endothelial cells and cardiac myocytes","volume":"33","author":"Balsubramanian","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"10.2353\/ajpath.2010.090621_bib12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1067\/mva.2000.107763b","article-title":"Opioid growth factor modulates angiogenesis","volume":"32","author":"Blebea","year":"2000","journal-title":"J Vasc Surg"},{"key":"10.2353\/ajpath.2010.090621_bib13","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/0306-3623(91)90580-Y","article-title":"Angiogenesis: modulation with opioids","volume":"22","author":"Pasi","year":"1991","journal-title":"Gen Pharmacol"},{"key":"10.2353\/ajpath.2010.090621_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10555-007-9066-y","article-title":"Hypoxia: a key regulator of angiogenesis in cancer","volume":"26","author":"Liao","year":"2007","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"10.2353\/ajpath.2010.090621_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-8674(01)00507-4","article-title":"Elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation","volume":"107","author":"Epstein","year":"2001","journal-title":"Cell"},{"key":"10.2353\/ajpath.2010.090621_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-5793(00)01181-9","article-title":"ERK activation upon hypoxia: involvement in HIF 1 activation","volume":"468","author":"Minet","year":"2000","journal-title":"FEBS Lett"},{"key":"10.2353\/ajpath.2010.090621_bib17","doi-asserted-by":"crossref","first-page":"32631","DOI":"10.1074\/jbc.274.46.32631","article-title":"p42\/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) and enhance the transcriptional activity of HIF-1","volume":"274","author":"Richard","year":"1999","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2010.090621_bib18","first-page":"4873","article-title":"The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1\u03b1","volume":"60","author":"Sodhi","year":"2000","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.090621_bib19","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0891-5849(01)00657-8","article-title":"Transduction pathways involved in Hypoxia-Inducible Factor-1 phosphorylation and activation","volume":"31","author":"Minet","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"10.2353\/ajpath.2010.090621_bib20","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1432-1033.2003.03446.x","article-title":"The subtle side to hypoxia inducible factor (HIF\u03b1) regulation","volume":"270","author":"Bilton","year":"2003","journal-title":"Eur J of Biochem"},{"key":"10.2353\/ajpath.2010.090621_bib21","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1101\/gad.1107303","article-title":"Mechanism of p38 MAP kinase activation in vivo","volume":"17","author":"Brancho","year":"2003","journal-title":"Genes Dev"},{"key":"10.2353\/ajpath.2010.090621_bib22","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1128\/MCB.25.12.4853-4862.2005","article-title":"Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling","volume":"25","author":"Emerling","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.2353\/ajpath.2010.090621_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mvr.2006.04.004","article-title":"Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation","volume":"72","author":"Singleton","year":"2006","journal-title":"Microvasc Res"},{"key":"10.2353\/ajpath.2010.090621_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1251\/bpo114","article-title":"Rapid and simple comparison of mRNA levels using real-time PCR","volume":"8","author":"Dussault","year":"2006","journal-title":"Biol Proceed Online"},{"key":"10.2353\/ajpath.2010.090621_bib25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1006\/mvre.1999.2233","article-title":"Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density","volume":"59","author":"Wild","year":"2000","journal-title":"Microvasc Res"},{"key":"10.2353\/ajpath.2010.090621_bib26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/107385840100700307","article-title":"The pharmacology of mu analgesics: from patients to genes","volume":"7","author":"Pasternak","year":"2001","journal-title":"Neuroscientist"},{"key":"10.2353\/ajpath.2010.090621_bib27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0022-3565(25)38099-7","article-title":"Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains","volume":"265","author":"Pick","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.2353\/ajpath.2010.090621_bib28","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1101-1194","article-title":"Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth","volume":"7","author":"Lyden","year":"2001","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2010.090621_bib29","first-page":"41","article-title":"Vascular endothelial growth factor is an autocrine survival factor for breast tumour cells under hypoxia","volume":"32","author":"Barr","year":"2008","journal-title":"Int J Oncol"},{"key":"10.2353\/ajpath.2010.090621_bib30","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1016\/S0021-9258(19)57475-0","article-title":"Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase","volume":"261","author":"Majamaa","year":"1986","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2010.090621_bib31","doi-asserted-by":"crossref","first-page":"9397","DOI":"10.1016\/S0021-9258(18)48093-3","article-title":"Reduction of collagen production in keloid fibroblast cultures by ethyl-3, 4-dihydroxybenzoate. Inhibition of prolyl hydroxylase activity as a mechanism of action","volume":"262","author":"Sasaki","year":"1987","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2010.090621_bib32","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1158\/1078-0432.CCR-08-2966","article-title":"Surgical stress promotes tumor growth in ovarian carcinoma","volume":"15","author":"Lee","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.2353\/ajpath.2010.090621_bib33","doi-asserted-by":"crossref","first-page":"22393","DOI":"10.1073\/pnas.0910753106","article-title":"Social isolation dysregulates endocrine and behavioral stress while increasing malignant burden of spontaneous mammary tumors","volume":"106","author":"Hermes","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.2353\/ajpath.2010.090621_bib34","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/jnr.10526","article-title":"Estrogen receptor-alpha is required for estrogen-induced mu-opioid receptor internalization","volume":"71","author":"Micevych","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.2353\/ajpath.2010.090621_bib35","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1074-5521(01)00056-4","article-title":"Proteasome inhibitors: from research tools to drug candidates","volume":"8","author":"Kisselev","year":"2001","journal-title":"Chem Biol"},{"key":"10.2353\/ajpath.2010.090621_bib36","doi-asserted-by":"crossref","first-page":"L1324","DOI":"10.1152\/ajplung.00326.2001","article-title":"Mitochondrial ROS initiate phosphorylation of p38 MAP kinase during hypoxia in cardiomyocytes","volume":"282","author":"Kulisz","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.2353\/ajpath.2010.090621_bib37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1042\/BJ20070186","article-title":"Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor-kappaB transcriptional activation in neuroblastoma SH-SY5Y cells","volume":"406","author":"Lin","year":"2007","journal-title":"Biochem J"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010601538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010601538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:00:56Z","timestamp":1757599256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010601538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0002944010601538"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2010.090621","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morphine Suppresses Tumor Angiogenesis through a HIF-1\u03b1\/p38MAPK Pathway","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.2353\/ajpath.2010.090621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}